BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22497771)

  • 1. Pathway-directed weighted testing procedures for the integrative analysis of gene expression and metabolomic data.
    Poisson LM; Sreekumar A; Chinnaiyan AM; Ghosh D
    Genomics; 2012 May; 99(5):265-74. PubMed ID: 22497771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MPINet: metabolite pathway identification via coupling of global metabolite network structure and metabolomic profile.
    Li F; Xu Y; Shang D; Yang H; Liu W; Han J; Sun Z; Yao Q; Zhang C; Ma J; Su F; Feng L; Shi X; Zhang Y; Li J; Gu Q; Li X; Li C
    Biomed Res Int; 2014; 2014():325697. PubMed ID: 25057481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative set enrichment testing for multiple omics platforms.
    Poisson LM; Taylor JM; Ghosh D
    BMC Bioinformatics; 2011 Nov; 12():459. PubMed ID: 22118224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between bivariate expression of key oncogenes and metabolic phenotypes of patients with prostate cancer.
    Khodayari Moez E; Pyne S; Dinu I
    Comput Biol Med; 2018 Dec; 103():55-63. PubMed ID: 30340213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer.
    Meller S; Meyer HA; Bethan B; Dietrich D; Maldonado SG; Lein M; Montani M; Reszka R; Schatz P; Peter E; Stephan C; Jung K; Kamlage B; Kristiansen G
    Oncotarget; 2016 Jan; 7(2):1421-38. PubMed ID: 26623558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: prostate cancer as a case.
    Liu W; Bai X; Liu Y; Wang W; Han J; Wang Q; Xu Y; Zhang C; Zhang S; Li X; Ren Z; Zhang J; Li C
    Sci Rep; 2015 Aug; 5():13192. PubMed ID: 26286638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
    Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
    Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes.
    Puhka M; Takatalo M; Nordberg ME; Valkonen S; Nandania J; Aatonen M; Yliperttula M; Laitinen S; Velagapudi V; Mirtti T; Kallioniemi O; Rannikko A; Siljander PR; Af Hällström TM
    Theranostics; 2017; 7(16):3824-3841. PubMed ID: 29109780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MSD-MAP: A Network-Based Systems Biology Platform for Predicting Disease-Metabolite Links.
    Wathieu H; Issa NT; Mohandoss M; Byers SW; Dakshanamurthy S
    Comb Chem High Throughput Screen; 2017; 20(3):193-207. PubMed ID: 28024464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene set analysis using sufficient dimension reduction.
    Hsueh HM; Tsai CA
    BMC Bioinformatics; 2016 Feb; 17():74. PubMed ID: 26852017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer.
    Shao Y; Ye G; Ren S; Piao HL; Zhao X; Lu X; Wang F; Ma W; Li J; Yin P; Xia T; Xu C; Yu JJ; Sun Y; Xu G
    Int J Cancer; 2018 Jul; 143(2):396-407. PubMed ID: 29441565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics study of key genes, metabolites, and pathways of periodontitis.
    Jun L; Yuanyuan L; Zhiqiang W; Manlin F; Chenrui H; Ouyang Z; Jiatong L; Xi H; Zhihua L
    Arch Oral Biol; 2023 Sep; 153():105720. PubMed ID: 37285682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3Omics: a web-based systems biology tool for analysis, integration and visualization of human transcriptomic, proteomic and metabolomic data.
    Kuo TC; Tian TF; Tseng YJ
    BMC Syst Biol; 2013 Jul; 7():64. PubMed ID: 23875761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Approach for Systems-Level Understanding of Prostate Cancer from High-Throughput Data Integration to Pathway Modeling and Simulation.
    Mobashir M; Turunen SP; Izhari MA; Ashankyty IM; Helleday T; Lehti K
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De-correlating expression in gene-set analysis.
    Nam D
    Bioinformatics; 2010 Sep; 26(18):i511-6. PubMed ID: 20823315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weighted multiple hypothesis testing procedures.
    Kang G; Ye K; Liu N; Allison DB; Gao G
    Stat Appl Genet Mol Biol; 2009; 8(1):Article23. PubMed ID: 19409067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests for differentiation in gene expression using a data-driven order or weights for hypotheses.
    Hommel G; Kropf S
    Biom J; 2005 Aug; 47(4):554-62. PubMed ID: 16161811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum.
    Penney KL; Tyekucheva S; Rosenthal J; El Fandy H; Carelli R; Borgstein S; Zadra G; Fanelli GN; Stefanizzi L; Giunchi F; Pomerantz M; Peisch S; Coulson H; Lis R; Kibel AS; Fiorentino M; Umeton R; Loda M
    Mol Cancer Res; 2021 Mar; 19(3):475-484. PubMed ID: 33168599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrete nonparametric algorithms for outlier detection with genomic data.
    Ghosh D
    J Biopharm Stat; 2010 Mar; 20(2):193-208. PubMed ID: 20309754
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.